
Tatva Chintan Pharma Chem Ltd Faces Technical Momentum Shift Amid Mixed Market Signals
2026-03-23 08:02:27Tatva Chintan Pharma Chem Ltd, a small-cap player in the Specialty Chemicals sector, has experienced a notable shift in its technical momentum, prompting a downgrade in its mojo grade from Buy to Hold as of 18 Dec 2025. Recent price action and technical indicators suggest a transition from a mildly bullish trend to a sideways or cautious stance, reflecting mixed signals for investors navigating this stock amid broader market volatility.
Read full news article
Tatva Chintan Pharma Chem Ltd is Rated Hold
2026-03-18 10:11:11Tatva Chintan Pharma Chem Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 18 Dec 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 18 March 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.
Read full news article
Tatva Chintan Pharma Chem Ltd Sees Mixed Technical Signals Amid Mildly Bullish Momentum
2026-03-11 08:03:52Tatva Chintan Pharma Chem Ltd has experienced a notable shift in its technical momentum, moving from a sideways trend to a mildly bullish stance. Despite a recent downgrade in its Mojo Grade from Buy to Hold, the stock’s price action and technical indicators reveal a complex interplay of bullish and bearish signals, warranting a nuanced analysis for investors navigating the specialty chemicals sector.
Read full news article
Tatva Chintan Pharma Chem Ltd Technical Momentum Shifts Amid Market Volatility
2026-03-10 08:05:01Tatva Chintan Pharma Chem Ltd, a key player in the specialty chemicals sector, has experienced a notable shift in its technical momentum, reflecting a complex interplay of bearish and mildly bullish indicators. Following a downgrade from a Buy to a Hold rating on 18 Dec 2025, the stock’s recent price action and technical signals suggest a sideways trend, challenging investors to reassess their positions amid volatile market conditions.
Read full news article
Tatva Chintan Pharma Chem Ltd is Rated Hold
2026-03-07 10:10:38Tatva Chintan Pharma Chem Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 18 Dec 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 07 March 2026, providing investors with the latest insights into its performance and outlook.
Read full news article
Tatva Chintan Pharma Chem Ltd Hits Intraday Low Amid Price Pressure
2026-03-04 12:41:13Tatva Chintan Pharma Chem Ltd experienced a notable decline today, touching an intraday low of Rs 1087, reflecting a 7.09% drop as the stock faced significant price pressure amid broader market volatility and sector underperformance.
Read full news article
Tatva Chintan Pharma Chem Ltd is Rated Hold
2026-02-24 10:11:08Tatva Chintan Pharma Chem Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 18 December 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 24 February 2026, providing investors with the latest insights into its performance and outlook.
Read full news article
Tatva Chintan Pharma Chem Ltd is Rated Hold
2026-02-12 10:11:11Tatva Chintan Pharma Chem Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 18 December 2025. However, the analysis and financial metrics discussed below reflect the company’s current position as of 12 February 2026, providing investors with an up-to-date view of the stock’s fundamentals, returns, and market standing.
Read full news article
Tatva Chintan Pharma Chem Ltd Hits Intraday High with 7.51% Surge on 9 Feb 2026
2026-02-09 10:33:57Tatva Chintan Pharma Chem Ltd recorded a robust intraday performance on 9 Feb 2026, surging to an intraday high of Rs 1,225, marking a 7.08% increase from its previous close. The stock outperformed its sector and broader market indices, signalling a notable reversal after three consecutive days of decline.
Read full news articleAnnouncement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
19-Mar-2026 | Source : BSEIntimation of Schedule of Analyst / Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015.
Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015
14-Mar-2026 | Source : BSEEnclosed
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
14-Mar-2026 | Source : BSEIntimation of Schedule of Analyst / Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015.
Corporate Actions
No Upcoming Board Meetings
Tatva Chintan Pharma Chem Ltd has declared 10% dividend, ex-date: 12 Sep 25
No Splits history available
No Bonus history available
No Rights history available






